Weird Links

Article discusses the use of dichloroacetate (DCA) in the successful treatment of lung, breast and brain cancers in cultured human cells and in live rats.

DCA works by reactivating dormant mictochondria in cancer cells, and apoptosis along with it; resulting in suicide of cancer cells, while the healthy surrounding tissue is unaffected.

Now apparently, the trouble is that DCA isn't patented, which means it can be produced dirt cheap. So, the big pharma companies won't invest in it because there's no profit to be made.

BTW, here's an insightful editorial about the whole mess - it's not as simple as the original article makes out.